Ke Ma
Impact in
- Pharmacology top 0.5%
- Fungal Biology and Applications
- Microbial Natural Products and Biosynthesis
- Phytochemistry and Bioactivity Studies
- Biological Psychiatry top 5%
Papers in
- Pharmacology 40
- Fungal Biology and Applications 30
- Microbial Natural Products and Biosynthesis 22
- Phytochemistry and Bioactivity Studies 10
- Journals
- Journal of Natural Products (5 papers)Planta Medica (4 papers)Fitoterapia (4 papers)Autophagy (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Ke Ma
81 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Pharmacology 979
- Pharmacology 336
- Biological Psychiatry 70
- Molecular Biology 1.7k
- Biotechnology 174
Countries citing papers authored by Ke Ma
This map shows the geographic impact of Ke Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Ma more than expected).
Fields of papers citing papers by Ke Ma
This network shows the impact of papers produced by Ke Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Ma. The network helps show where Ke Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 0 | |
| 6 | 2019 | 26 | |
| 7 | 2018 | 30 | |
| 8 | 2018 | 21 | |
| 9 | 2017 | 34 | |
| 10 | 2017 | 79 | |
| 11 | 2017 | 33 | |
| 12 | 2017 | 24 | |
| 13 | 2017 | 18 | |
| 14 | 2016 | 95 | |
| 15 | 2013 | 66 | |
| 16 | 2012 | 14 | |
| 17 | 2011 | 23 | |
| 18 | TGFBI gene mutation analysis in a Chinese pedigree of Reis-Bücklers corneal dystrophy. | 2010 | 12 |
| 19 | 2008 | 21 | |
| 20 | 2007 | 17 |
About Ke Ma
Ke Ma is a scholar working on Pharmacology, Pharmacology, Biochemistry, Molecular Biology and Cancer Research, having authored 85 papers that have together received 3.1k indexed citations. Recurring topics across this work include Fungal Biology and Applications (30 papers), Microbial Natural Products and Biosynthesis (22 papers), Plant biochemistry and biosynthesis (14 papers), Phytochemistry and Bioactivity Studies (10 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers), Zebrafish Biomedical Research Applications (5 papers), Phytochemical compounds biological activities (5 papers) and Marine Sponges and Natural Products (4 papers). The work is most often cited by research in Pharmacology (979 citations), Pharmacology (336 citations), Biological Psychiatry (70 citations), Molecular Biology (1.7k citations) and Biotechnology (174 citations). Ke Ma has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Hongwei Liu, Bao Li, Kai Wang, Wenzhao Wang, Chang Liu, Mingfang Liao, Shuang‐Jiang Liu, Junjie Han, Nan Zhou and Jun Wang. Their work appears in journals such as Journal of Natural Products, Planta Medica, Fitoterapia, Autophagy and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.